Bayer Hemophilia Awards Program recognizes Emory pediatric researcher
Bayer HealthCare has awarded a Bayer Hemophilia Awards Program (BHAP) Special Project grant to Dr. Christopher Doering, faculty member in Molecular and Systems Pharmacology.
The grant will help Doering continue his research on bioengineering factor VIII (FVIII) through "ancestral protein reconstruction." Doering will analyze the construction of ancient FVIII molecules that often have distinct properties that may or may not be anticipated from the study of FVIII in existing species. He hopes to design novel FVIII therapeutics that have enhanced properties for both protein infusion and gene therapy in patients with bleeding disorders.